Status:
COMPLETED
The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination
Lead Sponsor:
Royan Institute
Conditions:
Infertility
Eligibility:
FEMALE
25-30 years
Phase:
PHASE4
Brief Summary
According to the studies CC is successful at inducing ovulation in 50%-75% of cases, but only 30-40% becomes pregnant. The difference has been attributed to a negative action of clomifen citrate(CC) i...
Detailed Description
The proposal of This study approved by our institutional review boards and institution's ethical committee, and all Participants will sign a written consent before enter to study. All patients will be...
Eligibility Criteria
Inclusion
- The patients with first treatment cycle
- Age between 25 and 30 years,
- Infertility for at least 2 years' duration,
- Oligomenorrhea or amenorrhea associated with a positive Progesterone challenge test
- Women with normal concentrations of prolactin, free thyroxin and thyroid-stimulating hormone (TSH)
Exclusion
- Women whose partners had an abnormal semen analysis according to World Health Organization
- Women who had uterine or tubal abnormalities on hysterosalpingography, and women who had a body mass index of \>30 kg/m2.
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT01219101
Start Date
March 1 2011
End Date
February 1 2013
Last Update
November 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran